Civil Justice Magazine

Whatever you think of their products, there’s no denying – J&J always wins in appellate cases. Fernando A. Portes hired two lawyers – Herbert Tan and Eldridge Hawkins – to represent him in a discrimination lawsuit against Johnson & Johnson. He lost that lawsuit. So Mr. Portes tried again; this time, he sued his former […]

Read the full story

The contraceptive NuvaRing, made by Merck & Co., had some unexpected and potentially deadly side effects.  Allegedly, the device caused fatal blood clots – clots which induced heart attacks in some women. More than 1700 lawsuits were filed in Missouri and New Jersey; rather than continue in court, Merck has agreed to pay more than […]

Read the full story

The New York Daily News (1/31, Straw, 3.94M) reports in its “DC” blog that even though more people are being awarded monies from the 9/11 Victim Compensation Fund, the amount of claims being processed still aren’t enough – and they aren’t being processed at a fast enough rate. In mid-January of 2014, the VCF ruled that nearly […]

Read the full story

On Monday Feb. 3, Biomet became the latest company to make a settlement in a case against it involving defective hip implants. In a multidistrict litigation held in Indiana, Biomet agreed to pay at least $56 million to the hundreds of plaintiffs which filed against the medical device manufacturer. The case had been going on […]

Read the full story

The Pradaxa lawsuits are getting more and more complicated. A federal judge in Illinois has unsealed dozens of documents previously marked “confidential” in the multidistrict litigation against Boehringer Ingelheim International, makers of the blood thinner Pradaxa. The defendants originally claimed that these documents contained “nonpublic internal communications,” as well as “sensitive proprietary information” which could […]

Read the full story

In a stunning turn of events, Big Pharma giant Johnson & Johnson convinced the Louisiana Supreme Court to overturn a $258 million award against the J&J owned Janssen Pharmaceuticals, Inc. It’s a giant win for J&J, but a bitter pill to swallow for the affected parties. Long story short:  Janssen Pharmaceutica, Inc, markets an antipsychotic […]

Read the full story